Design of Clinical Trials of Radiation Combined With Antiangiogenic Therapy

Design of Clinical Trials of Radiation Combined With Antiangiogenic Therapy Suresh Senan, Egbert F. Smit Oncologist 2007; 12: 465-477 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in symptom management and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (required). Learning Objectives After completing this course, the reader should be able to: Discuss the impact of tumor angiogenesis and hypoxia on the outcome of radiation therapy. List the classes of antiangiogenic agents that are in clinical development. Identify mechanisms by which antiangiogenic therapy can enhance radiation efficacy. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Apr. 30, 2007 Most Recent Review: Apr. 30, 2007* Most Recent Update: Apr. 30, 2007 Date Credit Expires: Apr. 30, 2009 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.

• Take this course